Resveratrol Downregulates TNF-α-induced Monocyte Chemoattractant Protein-1 in Primary Rat Pulmonary Artery Endothelial Cells by P38 Mitogen-activated Protein Kinase Signaling

Overview

Journal Drug Des Devel Ther

Specialty Pharmacology

Date 2019 Jun 20

PMID 31213772

Citations 9

Authors

Jian-Wei Lin

Le-He Yang

Zhuo-Chao Ren

De-Guang Mu

Ya-Qing Li

Jian-Ping Yan

Liang-Xing Wang

Chun Chen

Affiliations

Soon will be listed here.

Abstract

To evaluate the effects of resveratrol to monocyte chemoattractant protein-1 (MCP-1) and the role of p38 mitogen-activated protein kinase (MAPK) in this process in vitro. Animal acute pulmonary thromboembolism (PTE) model: rat model was established by infusion of an autologous blood clot into the pulmonary artery through a polyethylene catheter. One hundred and thirty-two rats were randomly and equally divided into ten groups: rats-control (untreated), rats-1% DMSO, rats-TNF-α, rats-TNF-α + resveratrol, rats-TNF-α +C1142, rats-TNF-α+SB203580, rats-TNF-α+resveratrol + SB203580, rats-resveratrol only, rats-C1142 only, and rats-SB203580 only. Rat pulmonary artery endothelial cells (RPAs) tests: RPAs were isolated from above animal and designated as: RPAs-control, RPAs-1% DMSO control, RPAs-TNF-α, RPAs-TNF-α + resveratrol, RPAs-TNF-α + C1142, RPAs-TNF-α + SB203580, RPAs-TNF-α + resveratrol + SB203580, RPAs-resveratrol only, RPAs-C1142 only, and RPAs-SB203580 only. Each group was further divided into 1, 4, and 8 hrs time point for evaluation (n=6 rats per time point) except RPAs-TNF-α + SB203580, RPAs-TNF-α + resveratrol + SB203580, RPAs-C1142 and RPAs-SB203580 only, which were evaluated at 8 hrs time point. At each time point, mRNA and protein expressions of RPAs of MCP-1 were measured. The phosphorylation of p38 MAPK (p-pMAPK) of RPAs was also detected. We found that the RPAs-TNF-α elicited significant increases in MCP-1 expression and phosphorylation of p38 mitogen-activated protein kinase (p-p38 MAPK). Furthermore, the MCP-1 expressions of RPAs-Resveratrol, RPAs-C1142, and RPAs-SB203580 were significantly down-regulated, which was associated with robustly suppressed TNF-α-induced -p38MAPK expression. Our findings suggested that MCP-1 was involved in the formation of TNF-α-induced inflammatory response, and resveratrol could down-regulate the expression of MCP-1 via TNF-α- inhibition, which might contribute to the decline of acute PTE-induced PH in vivo.

Citing Articles

Natural Products for the Treatment of Pulmonary Hypertension: Mechanism, Progress, and Future Opportunities.

Zeng Z, Wang X, Cui L, Wang H, Guo J, Chen Y Curr Issues Mol Biol. 2023; 45(3):2351-2371.

PMID: 36975522 PMC: 10047369. DOI: 10.3390/cimb45030152.

Novel p38 Mitogen-Activated Protein Kinase Inhibitor Reverses Hypoxia-Induced Pulmonary Arterial Hypertension in Rats.

Silva G, Silva J, Nogueira de Alencar A, Silva M, Montagnoli T, de Souza Rocha B Pharmaceuticals (Basel). 2022; 15(7).

PMID: 35890198 PMC: 9316801. DOI: 10.3390/ph15070900.

Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials.

Shi Y, Zhang H, Huang S, Yin L, Wang F, Luo P Signal Transduct Target Ther. 2022; 7(1):200.

PMID: 35752619 PMC: 9233709. DOI: 10.1038/s41392-022-01055-2.

Resveratrol Inhibited ADAM10 Mediated CXCL16-Cleavage and T-Cells Recruitment to Pancreatic β-Cells in Type 1 Diabetes Mellitus in Mice.

Abdel-Bakky M, Alqasoumi A, Altowayan W, Amin E, A Darwish M Pharmaceutics. 2022; 14(3).

PMID: 35335970 PMC: 8955623. DOI: 10.3390/pharmaceutics14030594.

Unraveling the molecular mechanisms between inflammation and tumor angiogenesis.

Zhou W, Yang L, Nie L, Lin H Am J Cancer Res. 2021; 11(2):301-317.

PMID: 33575073 PMC: 7868762.

References

Strieter R, Kunkel S, Keane M, Standiford T . Chemokines in lung injury: Thomas A. Neff Lecture. Chest. 1999; 116(1 Suppl):103S-110S. DOI: 10.1378/chest.116.suppl_1.103s. View

Lee J, Kumar S, Griswold D, Underwood D, Votta B, Adams J . Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology. 2000; 47(2-3):185-201. DOI: 10.1016/s0162-3109(00)00206-x. View

Smulders Y . Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: the pivotal role of pulmonary vasoconstriction. Cardiovasc Res. 2000; 48(1):23-33. DOI: 10.1016/s0008-6363(00)00168-1. View

Kimura H, Okada O, Tanabe N, Tanaka Y, Terai M, Takiguchi Y . Plasma monocyte chemoattractant protein-1 and pulmonary vascular resistance in chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2001; 164(2):319-24. DOI: 10.1164/ajrccm.164.2.2006154. View

Eagleton M, Henke P, Luke C, Hawley A, Bedi A, Knipp B . Southern Association for Vascular Surgery William J. von Leibig Award. Inflammation and intimal hyperplasia associated with experimental pulmonary embolism. J Vasc Surg. 2002; 36(3):581-8. DOI: 10.1067/mva.2002.126556. View

Battistini B . Modulation and roles of the endothelins in the pathophysiology of pulmonary embolism. Can J Physiol Pharmacol. 2003; 81(6):555-69. DOI: 10.1139/y03-017. View

Langer F, Schramm R, Bauer M, Tscholl D, Kunihara T, Schafers H . Cytokine response to pulmonary thromboendarterectomy. Chest. 2004; 126(1):135-41. DOI: 10.1378/chest.126.1.135. View

Grumbles R, Casella G, Rudinsky M, Godfrey S, WOOD P, Thomas C . The immunophilin ligand FK506, but not the P38 kinase inhibitor SB203580, improves function of adult rat muscle reinnervated from transplants of embryonic neurons. Neuroscience. 2004; 130(3):619-30. DOI: 10.1016/j.neuroscience.2004.09.024. View

Rectenwald J, Deatrick K, Sukheepod P, Lynch E, Moore A, Moaveni D . Experimental pulmonary embolism: effects of the thrombus and attenuation of pulmonary artery injury by low-molecular-weight heparin. J Vasc Surg. 2006; 43(4):800-8. DOI: 10.1016/j.jvs.2005.12.010. View

10.

Green S, Han K, Chen Y, Almazan F, Charo I, Miller Y . The CC chemokine MCP-1 stimulates surface expression of CX3CR1 and enhances the adhesion of monocytes to fractalkine/CX3CL1 via p38 MAPK. J Immunol. 2006; 176(12):7412-20. DOI: 10.4049/jimmunol.176.12.7412. View

11.

Watts J, Zagorski J, Gellar M, Stevinson B, Kline J . Cardiac inflammation contributes to right ventricular dysfunction following experimental pulmonary embolism in rats. J Mol Cell Cardiol. 2006; 41(2):296-307. DOI: 10.1016/j.yjmcc.2006.05.011. View

12.

Ulrich S, Loitsch S, Rau O, von Knethen A, Brune B, Schubert-Zsilavecz M . Peroxisome proliferator-activated receptor gamma as a molecular target of resveratrol-induced modulation of polyamine metabolism. Cancer Res. 2006; 66(14):7348-54. DOI: 10.1158/0008-5472.CAN-05-2777. View

13.

Sener G, Topaloglu N, Sehirli A, Ercan F, Gedik N . Resveratrol alleviates bleomycin-induced lung injury in rats. Pulm Pharmacol Ther. 2006; 20(6):642-9. DOI: 10.1016/j.pupt.2006.07.003. View

14.

Cullen J, Morrow D, Jin Y, Curley B, Robinson A, Sitzmann J . Resveratrol, a polyphenolic phytostilbene, inhibits endothelial monocyte chemotactic protein-1 synthesis and secretion. J Vasc Res. 2006; 44(1):75-84. DOI: 10.1159/000098155. View

15.

Loberg R, Ying C, Craig M, Yan L, Snyder L, Pienta K . CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration. Neoplasia. 2007; 9(7):556-62. PMC: 1939930. DOI: 10.1593/neo.07307. View

16.

Zhu J, Yong W, Wu X, Yu Y, Lv J, Liu C . Anti-inflammatory effect of resveratrol on TNF-alpha-induced MCP-1 expression in adipocytes. Biochem Biophys Res Commun. 2008; 369(2):471-7. DOI: 10.1016/j.bbrc.2008.02.034. View

17.

Gresele P, Pignatelli P, Guglielmini G, Carnevale R, Mezzasoma A, Ghiselli A . Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. J Nutr. 2008; 138(9):1602-8. DOI: 10.1093/jn/138.9.1602. View

18.

Chakraborty P, Mustafi S, Raha S . Pro-survival effects of repetitive low-grade oxidative stress are inhibited by simultaneous exposure to Resveratrol. Pharmacol Res. 2008; 58(5-6):281-9. DOI: 10.1016/j.phrs.2008.08.007. View

19.

Park D, Baek K, Kim J, Lee J, Ryu S, Chin B . Resveratrol inhibits foam cell formation via NADPH oxidase 1- mediated reactive oxygen species and monocyte chemotactic protein-1. Exp Mol Med. 2009; 41(3):171-9. PMC: 2679243. DOI: 10.3858/emm.2009.41.3.020. View

20.

Shui H, Gao P, Si X, Ding G . Mycophenolic acid inhibits albumin-induced MCP-1 expression in renal tubular epithelial cells through the p38 MAPK pathway. Mol Biol Rep. 2009; 37(4):1749-54. DOI: 10.1007/s11033-009-9599-y. View